SearcharxivSearch

arXiv subjects

Matthew D. Sacchet

Publications and source records attributed to Matthew D. Sacchet.

7 recordsLinked to original sources

Machine Learning-Based Classification of Jhana Advanced Concentrative Absorption Meditation Using 7 Tesla Functional Magnetic Resonance Imaging

Introduction: Jhana advanced concentrative absorption meditation (ACAM-J) involves profound changes in consciousness, making its neural correlates important for understanding consciousness and well-being. Prior neuroimaging has relied on univariate, group-level contrasts, leaving open whether ACAM-J carries distributed neural signatures decodable from individual scans. This study evaluates whether fMRI-derived regional homogeneity (ReHo) can classify ACAM-J using machine learning. Methods: We analysed 7T fMRI data from 20 advanced meditators who progressed through their standard ACAM-J sequence and two matched control tasks, plus intensive data from one case-study participant held out for final evaluation. ReHo maps were computed per segment and parcellated into 498 regions spanning cortex, subcortex, brainstem, and cerebellum. Within subject-wise stratified cross-validation, feature ranking, recursive feature elimination, and class balancing were applied to training data only; six classifier families were fitted, and the top three per contrast were combined by probability averaging. Results: Across 19 binary comparisons, the ensemble reached an overall average accuracy of 65.87% before and 66.82% after regressing out phenomenology-related variance, with an average Cohen's \k{appa} of 0.2443. Discrimination was strongest for the most separated states (ACAM-J1 vs ACAM-J6, 74.33% accuracy, \k{appa} = 0.5158), while adjacent states were harder to separate. Prefrontal and anterior cingulate areas contributed most to model decisions. Conclusion: ReHo patterns measured at 7T carry information distinguishing ACAM-J from control states and, more modestly, from one another, supporting the feasibility of multivariate decoding of advanced meditation and informing future work on its mechanisms and neuromodulation.

cs.LG

Meditative absorption shifts brain dynamics toward criticality

Criticality describes a regime between order and chaos that supports flexible yet stable information processing. Here we examine whether neural dynamics can be volitionally shifted toward criticality through the self-regulation of attention. We examined ten experienced practitioners of meditation during a 10-day retreat, comparing refined states of meditative absorption, called the jhanas, to regular mindfulness of breathing. We collected electroencephalography (EEG) and physiological data during these practices and quantified the signal's dynamical properties using Lempel-Ziv complexity, signal entropy, chaoticity and long-range temporal correlations. In addition, we estimated perturbational sensitivity using a global auditory oddball mismatch negativity (MMN) during meditation. Relative to mindfulness, jhana was associated with pronounced self-reported sensory fading, slower respiration, higher neural signal diversity across multiple measures, reduced chaoticity, and enhanced MMN amplitude over frontocentral sites. Spectral analyses showed a flatter aperiodic one over f component and a frequency-specific reorganization of long-range temporal correlations. Together, increased diversity with reduced chaoticity and heightened deviance detection indicate a shift toward a metastable, near-critical regime during jhana. We propose an overlap of the phenomenology of jhana with minimal phenomenal experiences in terms of progressive attenuation of sensory content with preserved tonic alertness. Accordingly, our findings suggest that criticality is a candidate neurophysiological marker of the absorptive, minimal-content dimension of the minimal phenomenal experience.

q-bio.NC

Classification of Major Depressive Disorder Using Vertex-Wise Brain Sulcal Depth, Curvature, and Thickness with a Deep and a Shallow Learning Model

Major depressive disorder (MDD) is a complex psychiatric disorder that affects the lives of hundreds of millions of individuals around the globe. Even today, researchers debate if morphological alterations in the brain are linked to MDD, likely due to the heterogeneity of this disorder. The application of deep learning tools to neuroimaging data, capable of capturing complex non-linear patterns, has the potential to provide diagnostic and predictive biomarkers for MDD. However, previous attempts to demarcate MDD patients and healthy controls (HC) based on segmented cortical features via linear machine learning approaches have reported low accuracies. Here, we used globally representative data from the ENIGMA-MDD working group containing 7,012 participants from 30 sites (N=2,772 MDD and N=4,240 HC), which allows a comprehensive analysis with generalizable results. Based on the hypothesis that integration of vertex-wise cortical features can improve classification performance, we evaluated the classification of a DenseNet and a Support Vector Machine (SVM), with the expectation that the former would outperform the latter. We found that both classifiers exhibited close to chance performance (balanced accuracy DenseNet: 51%; SVM: 53%), when estimated on unseen sites. Slightly higher classification performance (balanced accuracy DenseNet: 58%; SVM: 55%) was found when the cross-validation folds contained subjects from all sites, indicating site effect. In conclusion, the integration of vertex-wise morphometric features and the use of the non-linear classifier did not lead to the differentiability between MDD and HC. Our results support the notion that MDD classification on this combination of such features and classifiers is unfeasible. Perhaps more sophisticated integration of multimodal information may lead to a higher performance in this diagnostic task.

q-bio.QM

Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures

Machine learning (ML) techniques have gained popularity in the neuroimaging field due to their potential for classifying neuropsychiatric disorders. However, the diagnostic predictive power of the existing algorithms has been limited by small sample sizes, lack of representativeness, data leakage, and/or overfitting. Here, we overcome these limitations with the largest multi-site sample size to date (n=5,356) to provide a generalizable ML classification benchmark of major depressive disorder (MDD). Using brain measures from standardized ENIGMA analysis pipelines in FreeSurfer, we were able to classify MDD vs healthy controls (HC) with around 62% balanced accuracy, but when harmonizing the data using ComBat balanced accuracy dropped to approximately 52%. Similar results were observed in stratified groups according to age of onset, antidepressant use, number of episodes and sex. Future studies incorporating higher dimensional brain imaging/phenotype features, and/or using more advanced machine and deep learning methods may achieve more encouraging prospects.

q-bio.QM

Deep Learning for Quality Control of Subcortical Brain 3D Shape Models

We present several deep learning models for assessing the morphometric fidelity of deep grey matter region models extracted from brain MRI. We test three different convolutional neural net architectures (VGGNet, ResNet and Inception) over 2D maps of geometric features. Further, we present a novel geometry feature augmentation technique based on a parametric spherical mapping. Finally, we present an approach for model decision visualization, allowing human raters to see the areas of subcortical shapes most likely to be deemed of failing quality by the machine. Our training data is comprised of 5200 subjects from the ENIGMA Schizophrenia MRI cohorts, and our test dataset contains 1500 subjects from the ENIGMA Major Depressive Disorder cohorts. Our final models reduce human rater time by 46-70%. ResNet outperforms VGGNet and Inception for all of our predictive tasks.

q-bio.NC

Machine Learning for Large-Scale Quality Control of 3D Shape Models in Neuroimaging

As very large studies of complex neuroimaging phenotypes become more common, human quality assessment of MRI-derived data remains one of the last major bottlenecks. Few attempts have so far been made to address this issue with machine learning. In this work, we optimize predictive models of quality for meshes representing deep brain structure shapes. We use standard vertex-wise and global shape features computed homologously across 19 cohorts and over 7500 human-rated subjects, training kernelized Support Vector Machine and Gradient Boosted Decision Trees classifiers to detect meshes of failing quality. Our models generalize across datasets and diseases, reducing human workload by 30-70\%, or equivalently hundreds of human rater hours for datasets of comparable size, with recall rates approaching inter-rater reliability.

q-bio.QM

Classification of Major Depressive Disorder via Multi-Site Weighted LASSO Model

Large-scale collaborative analysis of brain imaging data, in psychiatry and neu-rology, offers a new source of statistical power to discover features that boost ac-curacy in disease classification, differential diagnosis, and outcome prediction. However, due to data privacy regulations or limited accessibility to large datasets across the world, it is challenging to efficiently integrate distributed information. Here we propose a novel classification framework through multi-site weighted LASSO: each site performs an iterative weighted LASSO for feature selection separately. Within each iteration, the classification result and the selected features are collected to update the weighting parameters for each feature. This new weight is used to guide the LASSO process at the next iteration. Only the fea-tures that help to improve the classification accuracy are preserved. In tests on da-ta from five sites (299 patients with major depressive disorder (MDD) and 258 normal controls), our method boosted classification accuracy for MDD by 4.9% on average. This result shows the potential of the proposed new strategy as an ef-fective and practical collaborative platform for machine learning on large scale distributed imaging and biobank data.

cs.LG